Status:
COMPLETED
Cooperation for Better Treatment of Polypharmacy in the Community
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
South-Eastern Norway Regional Health Authority
Conditions:
Drug Usage
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The elderly population today relies heavily on medication consumption. While there are cases where using multiple medications is necessary and reasonable, it also increases the risk of inappropriate t...
Detailed Description
The aim of this study is to evaluate the effect of collaborative drug reviews by MipAC physicians, supervised by geriatricians, and FPs on clinically relevant outcome measures in the MipAC patient pop...
Eligibility Criteria
Inclusion
- Age 70+
- Admitted to the MipAC unit
- Use of at least six different systemic medications taken regularly
- Informed consent by the patient
Exclusion
- Previously included in the study
- Not speaking or understanding Norwegian
- Residing outside of the municipality of Oslo
- Planned discharge within 24 hours
- Isolated for infection control reasons
- Considered too ill to approach or life expectancy judged to be less than six months
- Personnel at the MipAC unit discourage participation (in case of important reasons not covered by the other exclusion criteria)
Key Trial Info
Start Date :
September 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2024
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT06020391
Start Date
September 6 2023
End Date
October 22 2024
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway